文拉法辛联合薄芝糖肽注射液治疗抑郁症的临床疗效观察  

The efficacy of venlafaxine combined with Bozhi glycopeptide injection in the treatment of tristimania

作　　者：祝红[1] 蒋国红[1] 于娜[1] 

机构地区：[1]贵州省遵义医学院附属医院神经内科,贵州遵义563003

出　　处：《现代预防医学》2013年第5期984-985,988,共3页Modern Preventive Medicine

摘　　要：目的评价文拉法辛与薄芝糖肽注射液联合治疗抑郁症的临床疗效。方法 40例抑郁症患者随机分成两组,治疗组予文拉法辛与薄芝糖肽注射液联合治疗,对照组单以文拉法辛治疗,疗程共8周。治疗前后采用汉密尔顿抑郁量表HAMD和汉密尔顿焦虑量表HAMA评分,观察两组患者的临床症状改善情况,评价观察疗效。结果文拉法辛联合薄芝糖肽注射液治疗抑郁症在治疗第2、4、8周总有效率分别为30%、75%、80%。单用文拉法辛治疗抑郁症在治疗第2、4、8周总有效率分别为10%、50%和75%。结论文拉法辛联合薄芝糖肽注射液治疗抑郁症的近期临床疗效高于单用文拉法辛。OBJECTIVE To evaluate the clinical therapeutic effect of venlafaxine and Bozhi glycopeptide injection on the tris- timania. METHODS 40 tristimania patients were divided randomly into 2 groups, and the patients in the treatment group were applied with venlafaxine and Bozhi glycopeptide injection, and the control group was only treated with venlafaxine. The course of treatment was 8 weeks for them. Clinical efficacy was evaluated by HAMD and HAMA before and after treatment. RESULTS The total effective rates of the treatment group were 30%, 75%, 80% and the rates of the control group were 10%, 50%, 75% on the 2^th, 4^th, 8^th weeks. CONCLUSION The short-term effect of venlafaxine combined with Bozhi glycopeptide injection is better than the venlafaxine alone in the treatment of tristimania.

关 键 词：抑郁症 文拉法辛 薄芝糖肽注射液 

分 类 号：R971.43[医药卫生—药品]